Alkermes To Put Its Long-Acting Stamp On Trusted Blockbusters, Starting With Abilify
This article was originally published in The Pink Sheet Daily
Executive Summary
Alkermes unveils patented, monthly injectable form of aripiprazole, developed without Bristol/Otsuka. Up next: Pfizer/Amgen's Enbrel.